Table 4.
INTP group (n = 165) | Control group (n = 150) | p-Value | |
---|---|---|---|
EMG changes (%) | 5 (3.0%) | 13 (8.7%) | 0.064 |
Hoarseness (%) | 2 (1.2%) | 8 (5.3%) | 0.037 |
Postoperative PTH (pg/ml) | 35.7 ± 17.4 | 35.3 ± 17.1 | 0.837 |
Postoperative calcium | 2.13 ± 0.12 | 2.15 ± 0.11 | 0.086 |
Numbness in limbs (%) | 18 (10.9%) | 16 (10.7%) | 0.945 |
Total number of CLN | 7.79 ± 4.63 | 7.19 ± 3.99 | 0.225 |
Number of metastatic CLN | 1.05 ± 1.91 | 1.23 ± 1.75 | 0.406 |
WBC (×109/L) | 9.9 ± 8.5 | 8.6 ± 2.7 | 0.086 |
Postoperative CRP (mg/L) | 8.0 ± 10.1 | 8.3 ± 7.9 | 0.826 |
Operative time (min) | 67.6 ± 28.2 | 74.6 ± 31.8 | 0.064 |
Hospital stay (days) | 3.2 ± 1.1 | 3.3 ± 1.1 | 0.392 |
Cosmetic satisfaction | 6.19 ± 1.22 | 5.98 ± 0.97 | 0.160 |
CLN, central lymph nodes; INTP, intraoperative neural tunnel protecting; EMG, electromyography; PTH, parathyroid hormone; WBC, white blood cell; CRP, C-reactive protein.